BioSpace News Archive

Oxford Nanopore sequencing technology has been used by a team led by researchers at the National Institutes of Health Center for Alzheimer’s and Related Dementias (CARD), the University of California, Santa Cruz and the National Cancer Institute, to develop a protocol for highly accurate whole human genome sequencing, at scale, that provides a comprehensive view of haplotype-resolved variation and methylation.

Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference.

Hyku Biosciences, Inc. (Hyku) today announced its launch with $56 million in seed financing to develop precision covalent medicines in oncology.

Danaher Corporation announced it will provide Cepheid’s Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis at Cepheid’s cost of $7.97 each to the Global Fund to Fight AIDS, TB and Malaria and to less-developed countries eligible for Cepheid’s Global Access Program1 to support greater access to high-quality TB testing.

ImmPACT Bio USA, Inc. announced that the first patient has been dosed in the Phase 1/2 trial evaluating IMPT-314, a bispecific CD19/CD20 CAR T-cell therapy for the treatment of relapsed or refractory (R/R) aggressive B-cell lymphoma.

Sutro Biopharma, Inc., a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates, announced the appointment of Hans-Peter Gerber, Ph.D., as Chief Scientific Officer, effective September 18, 2023.

PHAXIAM Therapeutics, announces the launch of a new preclinical development targeting a strong antimicrobial-resistant bacteria, Klebsiella pneumonia.

Pfizer Inc. announced that the European Commission has granted marketing authorization for LITFULO™ to treat adults and adolescents 12 years of age and older with severe alopecia areata.

MRM Health NV reports positive topline results from its Phase 2a clinical trial with MH002 in mild-to-moderate Ulcerative Colitis.

Oxford BioTherapeutics announces that its Chief Executive Officer, Christian Rohlff, will participate in the panel discussion titled “It takes a village: A holistic approach to external innovation” at Boehringer Ingelheim’s upcoming Transforming Science Day: Europe.